<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03968055</url>
  </required_header>
  <id_info>
    <org_study_id>48935</org_study_id>
    <nct_id>NCT03968055</nct_id>
  </id_info>
  <brief_title>Remote Monitoring of CGM Data in Pediatric Patients With Newly Diagnosed Type 1 Diabetes (T1D)</brief_title>
  <official_title>The Use of Continuous Glucose Monitor Technology and Remote Monitoring to Change Clinical Outcomes Following New Diagnosis of Type 1 Diabetes in the Pediatric Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if increased targeted contact between patients and the care team can improve
      diabetes outcomes in the 1st year after diagnosis. We will be using the GluVue platform to
      remotely view continuous glucose monitor (CGM) data. Based on alerts from GluVue, care team
      members will proactively reach out to patients and their families for more frequent dose
      adjustments. We will assess if remote monitoring facilitates contact between the care team
      and patients and improves glycemic control.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 25, 2019</start_date>
  <completion_date type="Anticipated">April 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Contacts with the care provider</measure>
    <time_frame>1 year</time_frame>
    <description>Prospective chart review to determine the number of contacts between the participant and care team due to remote monitoring</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin A1c</measure>
    <time_frame>1 year</time_frame>
    <description>Prospective chart review for lab values</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Type 1 Diabetes</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Integration with Epic</intervention_name>
    <description>Participants will have CGM data connected to our medical record through an already established pathway (Dexcom app on iOS device to Apple HealthKit to Epic MyChart to Epic)</description>
    <other_name>GluVue Platform</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All individuals within one month of T1D diagnosis seen at the Stanford Children's
             Diabetes Clinic

          -  Individuals who plan to receive follow up care at the Stanford Children's Diabetes
             Clinic

          -  Individuals who agree to CGM data integration into the electronic medical record (EMR)
             for remote monitoring

          -  Age: birth to &lt; 21 years of age

        Exclusion Criteria:

          -  Diabetes diagnosis other than T1D

          -  Diagnosis of diabetes &gt; 1 month prior to initial visit

          -  Individuals with the intention of obtaining diabetes care at another clinic

          -  Individuals who do not consent to CGM use, CGM data integration, or remote monitoring

          -  Individuals &gt; 21 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Priya Prahalad, MD, PhD</last_name>
    <phone>650-721-1811</phone>
    <email>prahalad@stanford.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ma Agnes Ith</last_name>
    <phone>50-497-4123</phone>
    <email>mith@stanford.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lucile Packard Children's Hospital</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Priya Prahalad, MD, PhD</last_name>
      <phone>650-721-1811</phone>
      <email>prahalad@stanford.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 28, 2019</study_first_submitted>
  <study_first_submitted_qc>May 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2019</study_first_posted>
  <last_update_submitted>May 28, 2019</last_update_submitted>
  <last_update_submitted_qc>May 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Priya Prahalad</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>pediatrics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

